Most common form of heart valve disease linked to unusual cholesterol
2013-02-07
(Press-News.org) Montreal, February 7th, 2013 – Researchers have discovered a gene associated with a form of cholesterol that increases the risk of developing aortic stenosis, the most common form of heart valve disease, by more than half. This international study, involving the Research Institute of the McGill University Health Centre (RI-MUHC), is the first of its kind to uncover a genetic link with aortic valve disease – a condition that affects more than 5 million people in North America.
The results of the study, published in the New England Journal of Medicine, point to the first known cause of aortic stenosis and to a potential treatment to prevent this disease. “We found that an unusual type of cholesterol called Lipoprotein (a) or Lp(a) – that is not normally screened for in current clinical practice – appears to be a cause of aortic valve disease,” says Dr. George Thanassoulis, one of the co-lead authors of the study, who is also director of preventive and genomic cardiology at the MUHC and an Assistant Professor in Medicine at McGill University. “High levels of this type of cholesterol are predicted primarily by an individual’s genetic make-up with only modest influence from lifestyle or other factors.”
Aortic stenosis (AS) is the third most prevalent form of cardiovascular disease in the western world, after hypertension and coronary artery disease. It mainly affects people over the age of 60 years. AS is caused by calcification and hardening of the aortic valve which impedes blood flow from the heart to the rest of the body leading to chest pain, loss of consciousness and shortness of breath. In severe cases, patients need aortic valve replacement surgery. Currently, there are no medical treatments to prevent this disease or reduce the need for valve replacement.
According to the study’s lead investigators – from the RI-MUHC, Johns Hopkins University, Harvard University, Washington University, the University of Iceland and the US National Institutes of Health – the findings not only explain why heart valve calcification may run in families, but could also lead to the development of targeted medications that might slow the progression of valve disease and reduce the need for valve surgery in patients.
“Previous studies could not differentiate whether Lp(a) was a cause or simply a marker of valve disease,” says Dr. Thanassoulis. “But our results strongly suggest a causal link and add to the mounting evidence that Lp(a) may be an important drug target for cardiovascular diseases.”
“This is an important step forward in understanding the biology of the development of aortic stenosis and how this common genetic variant, which is found in thirteen per cent of the general population, contributes to that risk,” says Dr. Wendy Post, a cardiologist and associate professor of medicine and epidemiology at the Johns Hopkins University School of Medicine who is a senior author of the study. “Advancing age is a major risk factor for aortic stenosis and, with the aging population this will become an even bigger health concern.”
Frequently used statin medications, which reduce the common form of cholesterol that clogs arteries, do not reduce Lp(a) or prevent aortic valve calcification. “Therefore, it is very important that these results benefit our patients,” says Dr. Thanassoulis. “For this to happen we need to test whether lowering this type of cholesterol with other drugs slows valve calcification in a randomized clinical trial. Our hope is to eventually prevent valve disease with medication and reduce the need for surgery.”
###
Funding
This work was funded by grants through the Canadian Institutes of Health Research (CIHR) and the National Heart, Lung, and Blood Institute as well as other funding agencies. Dr. Thanassoulis received funding from the CIHR, the Fonds de recherche du Québec – Santé (FRQS), the Royal College of Physician and Surgeons of Canada, the Association des Cardiologues du Québec and the Montreal General Hospital Foundation of the MUHC.
Useful links
The New England Journal of Medicine (NEJM): www.nejm.org/
McGill University Health Centre (MUHC): muhc.ca
Research Institute of the MUHC (RI-MUHC): muhc.ca/research
McGill University: mcgill.ca
Media
Julie Robert
Communications – Research
Public Affairs & Strategic Planning
McGill University Health Centre
Phone: 514-934-1934 (ext. 71381)
julie.robert@muhc.mcgill.ca END
ELSE PRESS RELEASES FROM THIS DATE:
2013-02-07
Older bikers are up to three times as likely to be seriously injured in a crash as younger motor bike enthusiasts, indicates US research published online in Injury Prevention.
The findings are a cause for concern, because of the increasing popularity of motor bike ownership among older adults, and their increasing tendency to be involved in a crash, warn the authors.
In the US, the percentage of bikers over the age of 50 has more than doubled from just over 1 in 10 in 1990 to 1 in 4 in 2003, while the average age of those involved in a motorbike crash has been steadily ...
2013-02-07
One in every 20 cases of the serious condition of pregnancy, pre-eclampsia, may be linked to increased levels of the air pollutant ozone during the first three months, suggests a large study published in the online journal BMJ Open.
Mothers with asthma may be more vulnerable, the findings indicate.
Pre-eclampsia is characterised by raised blood pressure and the presence of protein in the urine during pregnancy. It can cause serious complications, if left untreated.
The authors base their findings on almost 121,000 singleton births in Greater Stockholm, Sweden, between ...
2013-02-07
AMHERST, Mass. – Recently, large studies have identified some of the genetic basis for important common diseases such as heart disease and diabetes, but most of the genetic contribution to them remains undiscovered. Now researchers at the University of Massachusetts Amherst led by biostatistician Andrea Foulkes have applied sophisticated statistical tools to existing large databases to reveal substantial new information about genes that cause such conditions as high cholesterol linked to heart disease.
Foulkes says, "This new approach to data analysis provides opportunities ...
2013-02-07
A team led by Vanderbilt University investigators has discovered two new genes – both coding for the signaling protein calmodulin – associated with severe early-onset disorders of heart rhythm. The findings, reported online Feb. 6 in the journal Circulation, expand the list of culprits that can cause sudden cardiac death and may point to new therapeutic approaches.
Nearly two decades of research have identified more than 25 genes in which mutations can increase risk for life-threatening cardiac arrhythmias, said Alfred George, Jr., M.D., chief of the Division of Genetic ...
2013-02-07
MINNEAPOLIS/SAINT PAUL (February 6, 2013) – Researchers at the University of Minnesota have uncovered a human enzyme responsible for causing DNA mutations found in the majority of breast cancers. The discovery of this enzyme – called APOBEC3B – may change the way breast cancer is diagnosed and treated.
The findings from a team of researchers led by Reuben Harris, Ph.D., associate professor of biochemistry, molecular biology and biophysics and also a researcher at the Masonic Cancer Center, University of Minnesota, are published in the latest edition of Nature.
"We ...
2013-02-07
WASHINGTON, DC – Despite dire predictions in the wake of the economic crisis, donations to health projects in developing countries appear to be holding steady, according to new research from the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.
After reaching a historic high of $28.2 billion in 2010, development assistance for health dropped in 2011 and recovered in 2012. The strong growth in spending from the GAVI Alliance and UNICEF counterbalanced declines in health spending among other donors.
The new findings are being announced ...
2013-02-07
An automated supernova hunt is shedding new light on the death sequence of massive stars—specifically, the kind that self-destruct in Type IIn supernova explosions.
Digging through the Palomar Transient Factory (PTF) data archive housed at the Department of Energy's National Energy Research Scientific Computing Center (NERSC) at Lawrence Berkeley National Laboratory (Berkeley Lab), astronomers have found the first causal evidence that these massive stars shed huge amounts of material in a "penultimate outburst" before final detonation as supernovae.
A focused search ...
2013-02-07
The climate is getting warmer, and sea levels are rising – a threat to island nations. As a group of researchers lead by colleagues from the University of Bonn found out, at the same time, tiny single-cell organisms are spreading rapidly through the world's oceans, where they might be able to mitigate the consequences of climate change. Foraminifera of the variety Amphistegina are stabilizing coastlines and reefs with their calcareous shells. The study's results have now appeared in the international online journal "PLOS ONE."
Countless billions of tiny, microscopic ...
2013-02-07
Pasadena, CA—Type II supernovae are formed when massive stars collapse, initiating giant explosions. It is thought that stars emit a burst of mass as a precursor to the supernova explosion. If this process were better understood, it could be used to predict and study supernova events in their earliest stages. New observations from a team of astronomers including Carnegie's Mansi Kasliwal show a remarkable mass-loss event about a month before the explosion of a type IIn supernova. Their work is published on February 7 in Nature.
Several models for the supernova-creation ...
2013-02-07
TORONTO, Feb. 6, 2013—A popular class of drugs commonly used to treat sleep and mood symptoms continues to be frequently prescribed despite being known to have potentially life-threatening side effects.
Previous studies have linked benzodiazepines – a medication class that may be used in chronic obstructive pulmonary disease (COPD) to treat symptoms of insomnia, depression, anxiety and shortness of breath – with adverse outcomes, but until now there has been little information on how frequently it's prescribed or who is using it.
COPD, also known as emphysema or chronic ...
LAST 30 PRESS RELEASES:
[Press-News.org] Most common form of heart valve disease linked to unusual cholesterol
